Skip to main content
SpringerLink
Log in
Book cover

Encyclopedia of Pathology pp 1–10Cite as

Follicular Lymphoma

  • Living reference work entry
  • First Online:

  • 133 Accesses

Part of the book series: Encyclopedia of Pathology ((EP))

Definition

Follicular lymphoma (FL), in its usual form (UFL), is a malignant neoplasm composed of germinal center (GC) B cells, namely, centroblasts and centrocytes, which are presumed to originate from the GC light zone and usually display an at least partially follicular growth pattern (Swerdlow et al. 2016a). Particular FL variants include the pediatric-type FL, occurring mainly in children but also rarely in young adults, the duodenal–type FL, and a particular condition named in situ follicular neoplasia, which is considered as a precursor lesion with low rate of progression.

The definition of FL requires the lack of diffuse areas composed of large blastic cells, which should lead to the diagnosis of diffuse large cell lymphoma (DLCL), the most common type of FL transformation. Primary cutaneous lymphomas of follicular origin are not considered as bona fide FL variants and deserve a separate classification.

Clinical Features

Incidence, Age, and Sex

FL has its highest incidence in...

This is a preview of subscription content, log in via an institution.

References and Further Reading

  • Huet, S., Szafer-Glusman, E., Tesson, B., Xerri, L., Fairbrother, W. J., Mukhyala, K., Bolen, C., Punnoose, E., Tonon, L., Chassagne-Clément, C., Feugier, P., Viari, A., Jardin, F., Salles, G., & Sujobert, P. (2017a). BCL2 mutations do not confer adverse prognosis in follicular lymphoma patients treated with rituximab. American Journal of Hematology, 92, 515–519.

    Article  CAS  PubMed  Google Scholar 

  • Huet, S., Xerri, L., Tesson, B., Mareschal, S., Taix, S., Mescam-Mancini, L., Sohier, E., Carrère, M., Lazarovici, J., Casasnovas, O., Tonon, L., Boyault, S., Hayette, S., Haioun, C., Fabiani, B., Viari, A., Jardin, F., & Salles, G. (2017b). EZH2 alterations in follicular lymphoma: Biological and clinical correlations. Blood Cancer Journal, 7, e555.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jurinovic, V., Kridel, R., Staiger, A. M., Szczepanowski, M., Horn, H., Dreyling, M. H., Rosenwald, A., Ott, G., Klapper, W., Zelenetz, A. D., Barr, P. M., Friedberg, J. W., Ansell, S., Sehn, L. H., Connors, J. M., Gascoyne, R. D., Hiddemann, W.,Unterhalt, M., Weinstock, D. M., & Weigert, O. (2016). Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy. Blood, 128, 1112–1120.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kahl, B. S., & Yang, D. T. (2016). Follicular lymphoma: Evolving therapeutic strategies. Blood, 127, 2055–2063.

    Article  CAS  PubMed  Google Scholar 

  • Koch, K., Hoster, E., Ziepert, M., Unterhalt, M., Ott, G., Rosenwald, A., Hansmann, M. L., Bernd, W., Stein, H., Pöschel, V., Dreyling, M., Trümper, L., Löffler, M., Schmitz, N., Hiddemann, W., Pfreundschuh, M., & Klapper, W. (2016). Clinical, pathological and genetic features of follicular lymphoma grade 3A: A joint analysis of the German low-grade and high-grade lymphoma study groups GLSG and DSHNHL. Annals of Oncology, 27, 1323–1329.

    Article  CAS  PubMed  Google Scholar 

  • Kridel, R., Chan, F. C., Mottok, A., Boyle, M., Farinha, P., Tan, K., Meissner, B., Bashashati, A., McPherson, A., Roth, A., Shumansky, K., Yap, D., Ben-Neriah, S., Rosner, J., Smith, M. A., Nielsen, C., Giné, E., Telenius, A., Ennishi, D., Mungall, A., Moore, R., Morin, R. D., Johnson, N. A., Sehn, L. H., Tousseyn, T., Dogan, A., Connors, J. M., Scott, D. W., Steidl, C., Marra, M. A., Gascoyne, R. D., & Shah, S. P. (2016). Histological transformation and progression in follicular lymphoma: A clonal evolution study. PLoS Medicine, 13, e1002197.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Laurent, C., Baron, M., Amara, N., Haioun, C., Dandoit, M., Maynadié, M., Parrens, M., Vergier, B., Copie-Bergman, C., Fabiani, B., Traverse-Glehen, A., Brousse, N., Copin, M. C., Tas, P., Petrella, T., Rousselet, M. C., Brière, J., Charlotte, F., Chassagne-Clement, C., Rousset, T., Xerri, L., Moreau, A., Martin, A., Damotte, D., Dartigues, P., Soubeyran, I., Peoch, M., Dechelotte, P., Michiels, J. F., de Mascarel, A., Berger, F., Bossard, C., Arbion, F., Quintin-Roué, I., Picquenot, J. M., Patey, M., Fabre, B., Sevestre, H., Le Naoures, C., Chenard-Neu, M. P., Bastien, C., Thiebault, S., Martin, L., Delage, M., Filleron, T., Salles, G., Molina, T. J., Delsol, G., Brousset, P., & Gaulard, P. (2017). Impact of expert pathologic review of lymphoma diagnosis: Study of patients from the French Lymphopath Network. Journal of Clinical Oncology, 35, 2008–2017.

    Article  PubMed  Google Scholar 

  • Le, K. S., Thibult, M. L., Just-Landi, S., Pastor, S., Gondois-Rey, F., Granjeaud, S., Broussais, F., Bouabdallah, R., Colisson, R., Caux, C., Ménétrier-Caux, C., Leroux, D., Xerri, L., & Olive, D. (2016). Follicular B lymphomas generate regulatory T cells via the ICOS/ICOSL pathway and are susceptible to treatment by anti-ICOS/ICOSL therapy. Cancer Research, 76, 4648–4660.

    Article  CAS  PubMed  Google Scholar 

  • Leich, E., Hoster, E., Wartenberg, M., Unterhalt, M., Siebert, R., Koch, K., Klapper, W., Engelhard, M., Puppe, B., Horn, H., Staiger, A. M., Stuhlmann-Laeisz, C., Bernd, H. W., Feller, A. C., Hummel, M., Lenze, D., Stein, H., Hartmann, S., Hansmann, M. L., Möller, P., Hiddemann, W., Dreyling, M., Ott, G., Rosenwald, A., & German Low Grade Lymphoma Study Group (GLSG). (2016). Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locus. Leukemia, 30, 854–860.

    Article  CAS  PubMed  Google Scholar 

  • Louissaint, A., Jr., Schafernak, K. T., Geyer, J. T., Kovach, A. E., Ghandi, M., Gratzinger, D., Roth, C. G., Paxton, C. N., Kim, S., Namgyal, C., Morin, R., Morgan, E. A., Neuberg, D. S., South, S. T., Harris, M. H., Hasserjian, R. P., Hochberg, E. P., Garraway, L. A., Harris, N. L., & Weinstock, D. M. (2016). Pediatric-type nodal follicular lymphoma: A biologically distinct lymphoma with frequent MAPK pathway mutations. Blood, 128, 1093–1100.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mackrides, N., Campuzano-Zuluaga, G., Maque-Acosta, Y., Moul, A., Hijazi, N., Ikpatt, F. O., Levy, R., Verdun, R. E., Kunkalla, K., Natkunam, Y., Lossos, I. S., Vega, F., & Chapman, J. (2017). Epstein-Barr virus-positive follicular lymphoma. Modern Pathology, 30, 519–529.

    Article  CAS  PubMed  Google Scholar 

  • Miao, Y., Hu, S., Lu, X., Li, S., Wang, W., Medeiros, L. J., & Lin, P. (2016). Double-hit follicular lymphoma with MYC and BCL2 translocations: A study of 7 cases with a review of literature. Human Pathology, 58, 72–77.

    Article  CAS  PubMed  Google Scholar 

  • Quintanilla-Martinez, L., Sander, B., Chan, J. K., Xerri, L., Ott, G., Campo, E., & Swerdlow, S. H. (2016). Indolent lymphomas in the pediatric population: Follicular lymphoma, IRF4/MUM1+ lymphoma, nodal marginal zone lymphoma and chronic lymphocytic leukemia. Virchows Archiv, 468, 141–157.

    Article  CAS  PubMed  Google Scholar 

  • Sarkozy, C., Trneny, M., Xerri, L., Wickham, N., Feugier, P., Leppa, S., Brice, P., Soubeyran, P., Gomes Da Silva, M., Mounier, C., Offner, F., Dupuis, J., Caballero, D., Canioni, D., Paula, M., Delarue, R., Zachee, P., Seymour, J., Salles, G., & Tilly, H. (2016). Risk factors and outcomes for patients with follicular lymphoma who had histologic transformation after response to first-line Immunochemotherapy in the PRIMA trial. Journal of Clinical Oncology, 34, 2575–2582.

    Article  CAS  PubMed  Google Scholar 

  • Schmidt, J., Ramis-Zaldivar, J. E., Nadeu, F., Gonzalez-Farre, B., Navarro, A., Egan, C., Montes-Mojarro, I. A., Marafioti, T., Cabeçadas, J., van der Walt, J., Dojcinov, S., Rosenwald, A., Ott, G., Bonzheim, I., Fend, F., Campo, E., Jaffe, E. S., Salaverria, I., & Quintanilla-Martinez, L. (2017). Mutations of MAP 2K1 are frequent in pediatric-type follicular lymphoma and result in ERK pathway activation. Blood, 130, 323–327.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Siddiqi, I. N., Friedman, J., Barry-Holson, K. Q., Ma, C., Thodima, V., Kang, I., Padmanabhan, R., Dias, L. M., Kelly, K. R., Brynes, R. K., Kamalakaran, S., & Houldsworth, J. (2016). Characterization of a variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23 expression, 1p36/TNFRSF14 abnormalities, and STAT6 mutations. Modern Pathology, 29, 570–581.

    Article  CAS  PubMed  Google Scholar 

  • Swerdlow, S., Campo, E., Harris, N. E., Jaffe, E. S., Pileri, S. A., Stein, H., Thiele, J., & Vardiman, J. W. (2016a). WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press.

    Google Scholar 

  • Swerdlow, S. H., Kuzu, I., Dogan, A., Dirnhofer, S., Chan, J. K., Sander, B., Ott, G., Xerri, L., Quintanilla-Martinez, L., & Campo, E. (2016b). The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing. Virchows Archiv, 468, 259–275.

    Article  CAS  PubMed  Google Scholar 

  • Xerri, L., Dirnhofer, S., Quintanilla-Martinez, L., Sander, B., Chan, J. K., Campo, E., Swerdlow, S. H., & Ott, G. (2016). The heterogeneity of follicular lymphomas: From early development to transformation. Virchows Archiv, 468, 127–139.

    Article  CAS  PubMed  Google Scholar 

  • Xerri, L., Huet, S., Venstrom, J. M., Szafer-Glusman, E., Fabiani, B., Canioni, D., Chassagne-Clément, C., Dartigues-Cuilléres, P., Charlotte, F., Laurent, C., Gelas-Dore, B., Bolen, C. R., Punnoose, E., Bouabdallah, R., Brice, P., Morschhauser, F., Cartron, G., Olive, D., Salles, G., & a LYSA study. (2017). Rituximab treatment circumvents the prognostic impact of tumor-infiltrating T-cells in follicular lymphoma patients. Human Pathology, 64, 128–136.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Bio-Pathology, Institut Paoli-Calmettes, CRCM, INSERM, CNRS, Aix-Marseille Université, Marseille, France

    Luc Xerri

Authors
  1. Luc Xerri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Luc Xerri .

Editor information

Editors and Affiliations

  1. NIJMEGEN, The Netherlands

    J.H.J.M. van Krieken

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Xerri, L. (2018). Follicular Lymphoma. In: van Krieken, J. (eds) Encyclopedia of Pathology. Encyclopedia of Pathology. Springer, Cham. https://doi.org/10.1007/978-3-319-28845-1_3891-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-28845-1_3891-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-28845-1

  • Online ISBN: 978-3-319-28845-1

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation